Bioengineered Corneas Grafted as Alternatives to Human Donor Corneas in Three High‐Risk Patients
Autor: | Oleksiy Buznyk, Stanislav Iakymenko, Per Fagerholm, Nataliya Pasyechnikova, Mohammad Mirazul Islam, May Griffith |
---|---|
Rok vydání: | 2015 |
Předmět: |
collagen
Graft Rejection Male Time Factors medicine.medical_treatment patients Corneal Transplantation Implants Experimental Annan medicinsk grundvetenskap Tissue engineering Risk Factors Original Research Articles General Pharmacology Toxicology and Pharmaceutics Other Basic Medicine remodeling Aged 80 and over High risk patients General Neuroscience Endogenous regeneration General Medicine Transplant failure Middle Aged Tissue Donors Eye Burns Treatment Outcome Female medicine.medical_specialty Prosthesis Design General Biochemistry Genetics and Molecular Biology epithelium grafting transplantation Burns Chemical medicine Humans Corneal Ulcer Special Report Vision Ocular Corneal transplantation Aged Tissue Engineering Phosphorylcholine business.industry Recovery of Function corneal ulcer medicine.disease eye diseases Surgery Transplantation Special Reports sense organs business |
Zdroj: | Clinical and Translational Science |
ISSN: | 1752-8062 1752-8054 |
DOI: | 10.1111/cts.12293 |
Popis: | Corneas with severe pathologies have a high risk of rejection when conventionally grafted with human donor tissues. In this early observational study, we grafted bioengineered corneal implants made from recombinant human collagen and synthetic phosphorylcholine polymer into three patients for whom donor cornea transplantation carried a high risk of transplant failure. These patients suffered from corneal ulcers and recurrent erosions preoperatively. The implants provided relief from pain and discomfort, restored corneal integrity by promoting endogenous regeneration of corneal tissues, and improved vision in two of three patients. Such implants could in the future be alternatives to donor corneas for high-risk patients, and therefore, merits further testing in a clinical trial. Funding Agencies|Swedish Research Council (EU Nanomedicine project "I-CARE") [521-2012-5706]; Integrative Regenerative Medicine Centre, Linkoping, Sweden; Swedish Institute fellowship |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |